Synthesized flavone attenuates diabetes-induced neurodegeneration through regulation of oxidative stress and metabolic-neurodegenerative molecular pathways

Abstract

Flavone derivatives of natural products are often synthesized to enhance their structural specificity, target selectivity, and bioavailability. The current study aimed to examine the neuroprotective efficacy of flavone derivative in diabetic associated neurodegenerations through systematic assessments of in-silico and in-vivo. The synthesized flavone (2-phenyl-4H-chromen-4-one) was characterized by NMR spectroscopy and FTIR. The in-vivo assessments were performed by following the serum biochemistry of homeostatic model assessment (HOMA), antioxidant and histopathology of cortex and hippocampus. The in-silico assessment of molecular docking showed −6.6 Kcal/mol with dipeptidyl peptidase-4 enzyme (DPP4), −7.8 with acetylcholinesterase (AChE), and −9.5 with butyrylcholinesterase (BuChE). The diabetic neurodegeneration model was induced by the chemical induction method and treated with the test compound at a dose of 40 mg/kg in comparison to sitagliptin. The treatment of the test compound showed significant alterations in the cortex and hippocampus region with mitigated neuronal injuries which endorsed by expressions targeted genes including glucose transporter 3 (GLUT-3), glycogen synthase kinase 3 beta (GSK-3β), microtubule associated protein (MAP)-Tau, and peroxisome proliferator-activated receptor gamma (PPARγ). Furthermore, the lipid profile and oxidative stress were ameliorated significantly by the course of treatment. In conclusion, the synthesized flavone has significant capability to promote neuroprotective effects in diabetes associated neurodegeneration through mitigating oxidative stress and modulating the expression of the targeted genes, thereby alleviating neuronal injuries.

Keywords

GLUT-3 / GSK / MAP / PPARγ / diabetic associated neurodegenerations

References

[1] Vinayagam R, Xu B. Antidiabetic properties of dietary flavonoids: a cellular mechanism review. Nutr Metab. 2015; 12(1): 60.

[2] Kshatriya R, Shaikh Y, Nazeruddin G. Synthesis of flavone skeleton by different methods. Orient J Chem. 2013; 29(4): 1475-1487.

[3] Ibrahim MAA, Mohamed EAR, Abdelrahman AHM, et al. Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: in silico drug discovery study. J Mol Graph Model. 2021; 105(January): 107904.

[4] Teleszko M, Wojdyło A, Rudzińska M, Oszmiański J, Golis T. Analysis of lipophilic and hydrophilic bioactive compounds content in sea buckthorn (Hippophaë rhamnoides L.) berries. J Agricult Food Chem. 2015; 63(16): 4120-4129.

[5] Kaliora AC, Dedoussis GVZ, Schmidt H. Dietary antioxidants in preventing atherogenesis. Atherosclerosis. 2006; 187(1): 1-17.

[6] Oh Youngse, Lee Dahae, Park SeonJu, Kim SeungHyun, Kang KiSung. The chemical constituents from fruits of catalpa bignonioides. Molecules. 2021; 26(362): 1-15.

[7] Cabrera M, Simoens M, Falchi G, et al. Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure – activity relationships. Bioorg Med Chem. 2007; 1515: 3356-3367.

[8] Shan G, Yang X, Ma L, Rao Y. Angewandte Pd-catalyzed C À H oxygenation with TFA/TFAA: expedient access to oxygen-containing heterocycles and late-stage drug modification. Angew Chem Int Ed. 2012; 51: 13070-13074.

[9] Horna-Rodriguez Alexsandra M, López-Gamboa July A, Silva-Correa Carmen R, Sagástegui-Guarniz William A, Gamarra-Sánchez César D, et al. In silico analysis of the polyphenolic metabolites of Zea mays L. “purple corn” on HMG-CoA reductase. Pharmacognosy J. 2022; 14(3): 549-558.

[10] Fintelman-rodrigues N, Wang X, Sacramento CQ, Temerozo JR, Ferreira AC, et al. Commercially available flavonols are better SARS-CoV-2 inhibitors than isoflavone and flavones. Virues. 2022; 14(1458): 1-17.

[11] Madanagopal P, Ramprabhu N, Jagadeesan R. In silico prediction and structure-based multitargeted molecular docking analysis of selected bioactive compounds against mucormycosis. Bull Natl Res Centre. 2022; 46(1): 24.

[12] Deshmukh R, Kaundal M, Bansal V, Samardeep . Caffeic acid attenuates oxidative stress, learning and memory deficit in intra-cerebroventricular streptozotocin induced experimental dementia in rats. Biomed Pharmacother. 2016; 81: 56-62.

[13] Jing YH, Chen KH, Kuo PC, Pao CC, Chen JK. Neurodegeneration in streptozotocin-induced diabetic rats is attenuated by treatment with resveratrol. Neuroendocrinology. 2013; 98(2): 116-127.

[14] S P, R R, R K. Blood sample collection in small laboratory animals. J Pharmacol Pharmacother. 2010; 1(2): 87-93.

[15] Rispin A, Farrar D, Margosches E, et al. Alternative methods for the median lethal dose (LD50) test: the up-and-down procedure for acute oral toxicity. ILAR J. 2002; 43(4): 233-243.

[16] Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem: Int J Lab Med. 1969; 6(1): 24-27.

[17] Lowry O, Rosebrough N, Farr AL, Randall R. Protein measurement with the folin phenol reagent. J Biol Chem. 1951; 193(1): 265-275.

[18] Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974; 20(4): 470-475.

[19] Gottfried SP, Rosenberg B. Improved manual spectrophotometric procedure for determination of serum triglycerides. Clin Chem. 1973; 19(9): 1077-1078.

[20] Hirano T, Nohtomi K, Koba S, Muroi A, Ito Y. A simple and precise method for measuring HDL-cholesterol subfractions by a single precipitation followed by homogenous HDL-cholesterol assay. J Lipid Res. 2008; 49(5): 1130-1136.

[21] Gowda YS, N AR, Rajeshwari A, Somashekar GN, Nusrath A. Atherogenic predictor indices: role in assessment of cardiovascular risk in type 2 diabetes mellitus. IOSR J Biotechnol Biochem. 2019; 5(4): 36-41.

[22] Njie-Mbye YF, Kulkarni-Chitnis M, Opere CA, Barrett A, Ohia SE. Lipid peroxidation: pathophysiological and pharmacological implications in the eye. Front Physiol. 2013; 4: 366.

[23] Gaucher C, Boudier A, Bonetti J, Clarot I, Leroy P, Parent M. Glutathione: antioxidant properties dedicated to nanotechnologies. Antioxidants. 2018; 7(5): 62.

[24] Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem. 1996; 239(1): 70-76.

[25] Matthews DR, Hosker JP, Rudenski aS, Naylor Ba, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7): 412-419.

[26] Kumar S, Chowdhury S, Razdan A, et al. Downregulation of candidate gene expression and neuroprotection by piperine in streptozotocin-induced hyperglycemia and memory impairment in rats. Front Pharmacol. 2021; 11(March): 1-18.

[27] Mohamed NH, Elsayad H, Elsherbini YM, Abdraboh ME. Neuroprotective effect of peanut against oxidative stress in streptozotocin-induced diabetic rats. Egypt J Basic Appl Sci. 2022; 9(1): 542-559.

[28] Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques. 1993; 15(3): 532-534.

[29] Priščáková P, Minárik G, Repiská V. Candidate gene studies of diabetic retinopathy in human. Mol Biol Rep. 2016; 43: 1327-1345.

[30] Sharkey FH, Banat IM, Marchant R. Detection and quantification of gene expression in environmental bacteriology. Appl Environ Microbiol. 2004; 70(7): 3795-3806.

[31] Haneef K, Naeem N, Iqbal H, Kabir N. Gene expression pattern in rat bone marrow mesenchymal stem cells in response to hypoxia gene expression pattern in rat bone marrow mesenchymal stem cells in response to hypoxia. Pak J Biochem Mol Biol. 2010; 43(2): 90-93.

[32] Madhusudhanan J, Suresh G, Devanathan V. Neurodegeneration in type 2 diabetes: Alzheimer's as a case study. Brain Behav. 2020; 10(5): 1-13.

[33] Ristow M. Neurodegenerative disorders associated with diabetes mellitus. J Mol Med. 2004; 82: 510-529.

[34] Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest. 1998; 102(August): 783-791.

[35] Farhadi A, Vosough M, Zhang JS, Tahamtani Y, Shahpasand K. A possible neurodegeneration mechanism triggered by diabetes. Trends Endocrinol Metab. 2019; 30(10): 692-700.

[36] Bansal R, Singh R. Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: a literature review. Med Res Rev. 2017; 38(4): 1126-1158.

[37] Venkatesan R, Ji E, Kim SY. Phytochemicals that regulate neurodegenerative disease by targeting neurotrophins: A comprehensive review. BioMed Res Int. 2015; 2015: 1-22.

[38] Lane RM, Potkin SG, Enz A. Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int J Neuropsychopharmacol. 2006; 9(1): 101-124.

[39] Hurrle S, Hsu WH. The etiology of oxidative stress in insulin resistance. Biomed J. 2017; 40(5): 257-262.

[40] Dewangan H, Tiwari RK, Sharma V, Shukla SS, Satapathy T, Pandey R. Past and future of in-vitro and in-vivo animal models for diabetes: a review. Indian J Pharm Educ Res. 2017; 51(4): s522-s530.

[41] Solayman M, Ali Y, Alam F, et al. Polyphenols: potential future arsenals in the treatment of diabetes. Curr Pharm Des. 2016; 22(5): 549-565.

[42] Chung S, Hwang J, Park S. Physiological effects of bioactive compounds derived from whole grains on cardiovascular and metabolic diseases well various bioactive comp. Appl Sci. 2022; 12(658): 1-25.

[43] Akpoveso OOP, Ubah EE, Obasanmi G. Antioxidant phytochemicals as potential therapy for diabetic complications. Antioxidants. 2023; 12: 123.

[44] Abo-Zaid OA, Moawed FS, Ismail ES, Farrag MA. β-sitosterol attenuates high-fat diet-induced hepatic steatosis in rats by modulating lipid metabolism, inflammation and ER stress pathway. BMC Pharmacol Toxicol. 2023; 24(1): 31.

[45] Hottin C, Perron M. Challenging therapeutic target. Cells. 2022; 11: 1-21.

[46] Tang D, Chen QB, Xin XL, Aisa HA. Anti-diabetic effect of three new norditerpenoid alkaloids in vitro and potential mechanism via PI3K/Akt signaling pathway. Biomed Pharmacother. 2017; 87: 145-152.

[47] Iqbal K, Liu F, Gong CX, Grundke-Iqbal I. Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res. 2010; 7(8): 656-664.

Rights & permissions

2026 The Author(s). Ibrain published by Affiliated Hospital of Zunyi Medical University (AHZMU) and Wiley-VCH GmbH.